These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 38625505)

  • 1. Cancer-associated fibroblasts-derived exosomal METTL3 promotes the proliferation, invasion, stemness and glutaminolysis in non-small cell lung cancer cells by eliciting SLC7A5 m6A modification.
    Fan Y; Yu Y
    Hum Cell; 2024 Jul; 37(4):1120-1131. PubMed ID: 38625505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 in cancer-associated fibroblasts-derived exosomes promotes the proliferation and metastasis and suppresses ferroptosis in colorectal cancer by eliciting ACSL3 m6A modification.
    Ren H; Wang M; Ma X; An L; Guo Y; Ma H
    Biol Direct; 2024 Aug; 19(1):68. PubMed ID: 39160584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.
    Liu C; Ren Q; Deng J; Wang S; Ren L
    Biomed J; 2024 Aug; 47(4):100664. PubMed ID: 37774794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via METTL3-mediated RAC3 m
    Chen M; Zhang Q; Zheng S; Guo X; Cao L; Ren Y; Qian Y; Wang M; Wu X; Xu K
    Int J Biol Sci; 2023; 19(5):1616-1632. PubMed ID: 37056933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1.
    Bai W; Xiao G; Xie G; Chen Z; Xu X; Zeng J; Xie J
    Thorac Cancer; 2024 Sep; 15(26):1871-1881. PubMed ID: 39090761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRPL35 Induces Proliferation, Invasion, and Glutamine Metabolism in NSCLC Cells by Upregulating SLC7A5 Expression.
    Hou W; Chen J; Wang Y
    Clin Respir J; 2024 Jul; 18(7):e13799. PubMed ID: 38987867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts derived exosomal LINC01833 promotes the occurrence of non-small cell lung cancer through miR-335-5p -VAPA axis.
    Chen J; Sun JJ; Ma YW; Zhu MQ; Hu J; Lu QJ; Cai ZG
    J Biochem Mol Toxicol; 2024 Sep; 38(9):e23769. PubMed ID: 39152098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.
    He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y
    Mol Cell Biochem; 2024 Jul; 479(7):1707-1720. PubMed ID: 38822192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Associated Fibroblasts Hinder Lung Squamous Cell Carcinoma Oxidative Stress-Induced Apoptosis via METTL3 Mediated m
    Li Y; Li X; Deng M; Ye C; Peng Y; Lu Y
    Oxid Med Cell Longev; 2022; 2022():4320809. PubMed ID: 36246404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
    Xie H; Yao J; Wang Y; Ni B
    Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3-mediated the m6A modification of SF3B4 facilitates the development of non-small cell lung cancer by enhancing LSM4 expression.
    He G; Gu K; Wei J; Zhang J
    Thorac Cancer; 2024 Apr; 15(11):919-928. PubMed ID: 38462740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.
    Zhang Y; Liu S; Zhao T; Dang C
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34132367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X; Wang Z; Lu W; Miao L; Zhao Y
    BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal circHIF1A derived from hypoxic-induced carcinoma-associated fibroblasts promotes hepatocellular carcinoma cell malignant phenotypes and immune escape.
    Shang H; Lu L; Fan M; Lu Y; Shi X; Lu H
    Int Immunopharmacol; 2024 Sep; 138():112282. PubMed ID: 38936058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging.
    Zhang T; Zhang P; Li HX
    Int J Nanomedicine; 2021; 16():561-577. PubMed ID: 33542625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal circ_0007385 enhances non-small cell lung cancer cell proliferation and stemness via regulating miR-1253/FAM83A axis.
    Ning Z; Tian Y; Li Y; Zhao X; Zhang J; Wang C; Hu J; Shen H; Wu W
    Anticancer Drugs; 2022 Jan; 33(1):61-74. PubMed ID: 34620741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer.
    Wang H; Huang H; Wang L; Liu Y; Wang M; Zhao S; Lu G; Kang X
    Aging (Albany NY); 2021 May; 13(10):14456-14468. PubMed ID: 33999859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfonylurea receptor 1-expressing cancer cells induce cancer-associated fibroblasts to promote non-small cell lung cancer progression.
    Chen H; Zhao L; Meng Y; Qian X; Fan Y; Zhang Q; Wang C; Lin F; Chen B; Xu L; Huang W; Chen J; Wang X
    Cancer Lett; 2022 Jun; 536():215611. PubMed ID: 35240233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2.
    Wang D; Zhao C; Xu F; Zhang A; Jin M; Zhang K; Liu L; Hua Q; Zhao J; Liu J; Yang H; Huang G
    Theranostics; 2021; 11(6):2860-2875. PubMed ID: 33456577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.